📰 Discovery Sciences News
Page 4 - Discovery Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Discovery Sciences. Real-time updates on events, politics, business and more.
May 20, 2022
/PRNewswire/ -- Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the...
May 20, 2022
Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.
May 20, 2022
BIRMINGHAM, England, May 20, 2022 /PRNewswire/ -- Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory
May 20, 2022
Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response
May 4, 2022
PARIS, May 4, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and
April 12, 2022
SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointments
January 26, 2022
Forty finalists have now made the shortlist for the forthcoming Scottish Apprenticeship Awards 2022 – with all hoping to follow in the…
December 17, 2021
Basel, Switzerland (PRWEB) December 17, 2021 -- Genedata, a leading provider of enterprise software solutions for biopharma R&D, today announced an expanded
May 17, 2021
/PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of Percy Carter, MBA, Ph.D., as Chief Scientific Officer,...
April 9, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ONCURIOUS Presenting Clinical and Preclinical Data at Upcoming American Association for Cancer ... Oxurion NVApril 9, 2021 GMT Oral presentation of Phase 1 dose escalation study of TB-403 in pediatric subjects with relapsed or refractory medulloblastoma (MB) Poster presentation of research findings of best therapeutic approach to target CCR8 expressed on tumor regulatory T cells to boost anti-tumor im...